Toru Kita

Kyoto University

Papers

1

Total Citations

53

H-Index

1

About

Toru Kita is a pioneering researcher in diabetic nephropathy and the molecular mechanisms underlying diabetic complications. His work has fundamentally advanced our understanding of how advanced glycation end products (AGEs) drive kidney damage in diabetes. In his landmark 2004 study, cited over 50 times, Kita demonstrated that AGEs upregulate HSP47, a collagen-specific chaperone protein, in mouse models of diabetic nephropathy. This discovery revealed a critical link between metabolic stress and pathological collagen accumulation in the kidney. By showing that the AGE inhibitor OPB-9195 could suppress HSP47 expression, Kita identified a potential therapeutic target for preventing renal fibrosis. His research bridges basic molecular biology with clinical relevance, offering mechanistic insights that have guided subsequent studies on diabetic kidney disease. Kita's contributions have been instrumental in shaping current approaches to understanding and treating diabetic complications, making him a respected figure in nephrology and diabetes research.

Research Focus

Key Achievements

1
H-Index
1
Papers
53
Total Citations
53
Avg Citations/Paper
🏆 Most Cited Paper
Advanced Glycation End Products Increase Collagen-specific Chaperone Protein in Mouse Diabetic Nephropathy
53 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Kyoto University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago